Hey guys, instead of arguing, can we just discuss what my previous post actually means. Anyone that has been around a while with mesoblast knows that silviu has played with words in the past which indicated more positive results than they actually were. I am a fan of mesoblast but I also was one that was fooled when the back pain results came out and silviu made it sound like they met primary end point when they didn’t. So let’s discuss why they left out the actual numbers for improvement in ejection fraction. What is an increase of 5? Is it 5% or are they referring to another score?
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE, page-96
-
- There are more pages in this discussion • 204 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |